Kastrasi Kimia dalam Manajemen Kejahatan Seksual terhadap Anak: Tinjauan Medis

William .

Abstract

Kejahatan seksual terhadap anak merupakan pelanggaran hukum serius dan kasusnya terus bertambah. Kadar testosteron yang tinggi diduga berkontribusi pada kasus kejahatan seksual; sehingga selain harus dipidana sesuai ketentuan yang berlaku, pelaku juga perlu ditatalaksana dari sisi medis. Salah satu alternatif terapi medis yang dapat dipertimbangkan adalah kastrasi kimia, yaitu supresi libido pelaku menggunakan agen kimia. Studi menunjukkan bahwa kastrasi kimia 80-90% efektif mencegah pelaku menjadi residivis. Meskipun penerapannya masih dilematis, kastrasi kimia dapat menjadi pilihan yang efektif apabila sesuai indikasi.

Full Text:

PDF

References

Ratkoceri V. Chemical castration of child molesters – Right or wrong? Eur J Soc Sci. 2017;11(1):70-6.

Evans CT, Ward C. Counseling sex offenders and the importance of counselor self-care. Cogent Soc Sci. 2019;5(1):1595878.

Hanson RK, Yates PM. Psychological treatment of sex offenders. Curr Psychiatr Rep. 2013;15:348.

Marthasari RS. Sex offenders: Treat or punish? (Community quick survey on sex offenders). Anima Indonesia Psychological J. 2016;31(3):143-8.

Lee JY, Cho KS. Chemical castration for sexual offenders: Physicians’ view. J Korean Med Sci. 2013;28:171-2.

Presiden Republik Indonesia. Peraturan Pemerintah Republik Indonesia Nomor 70 Tahun 2020 tentang Tata Cara Pelaksanaan Tindakan Kebiri Kimia, Pemasangan Alat Pendeteksi Elektronik, Rehabilitasi, dan Pengumuman Identitas Pelaku Kekerasan Seksual terhadap Anak. 2020.

De Baca LC. Sex offender management assessment and planning initiative (SOMAPI) research brief. United States Department of Justice; 2015.

Lembaga Perlindungan Saksi dan Korban. 2020.

Selek A, Bolu SE. Testosterone and sexual offending: From pathophysiology to treatment. Turk J Endocrinol Metab. 2018;22:254-59.

Rodriguez CM, Granger DA, Leerkes EM. Testosterone associations with parents’ child abuse risk and at-risk parenting: A multimethod longitudinal examination. Child Maltreatment. 2021;26(1):50-62.

Turner D, Briken P. Treatment of paraphilic disorders in sexual offenders or men with a risk of sexual offending with luteinizing hormone-releasing hormone agonists: An updated systematic review. J Sex Med. 2018;15:77-93.

Atmaca M. Selective serotonin reuptake inhibitor-Induced sexual dysfunction: Current management perspectives. Neuropsychiatr Dis Treat. 2020;16:1043-50.

Chu A, Wadhwa R. Selective serotonin reuptake inhibitors [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554406/.

Booth BD. How to select pharmacologic treatments to manage recidivism risk in sex offenders. Curr Psychiatr. 2009;8(10):60-72.

Lippi G, Van Staden PJ. The use of cyproterone acetate in a forensic psychiatric cohort of male sex offenders and its associations with sexual activity and sexual functioning. S Afr J Psychiatr. 2017;23:982.

Fitzgerald EA. Chemical castration: MPA treatment of the sexual offender. 18 Am J Crim L. 1990;18:1.

Usfunan Y, Usfunan JZ, Putra IPRA. The constitutionality of castration sanction. IRCS Unud J. 2017;1(1):121-6.

Majelis Kehormatan Etik Kedokteran. Kode etik kedokteran Indonesia. Jakarta: Pengurus Besar Ikatan Dokter Indonesia; 2012.

Refbacks

  • There are currently no refbacks.